RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT
Sodium Nitrite May Have More Protective Roles for Humans than Just Being Useful in Treating Cyanide Poisoning

Apr 17, 2005 - 9:41:00 AM
"The remarkable thing about nitrite is that it is only converted to nitric oxide in the organs and tissues with the lowest oxygen levels, allowing for targeted NO delivery - and thus improved blood flow -- to tissues under stress. More research is needed to look at the effectiveness of nitrite in various organs and disease states in humans."

 
[RxPG] Sodium nitrite, a naturally occurring chemical and common meat preservative, is only used medically to treat cyanide poisoning. But if the results of a new animal study hold up under further research in people, the chemical may one day be used to protect and preserve tissue and organ function after heart attack, high risk abdominal surgery, and organ transplantation.

The new study was conducted by scientists with the National Heart, Lung, and Blood Institute ( NHLBI ) of the National Institutes of Health ( NIH ) in collaboration with investigators supported by the National Institute of Diabetes and Digestive and Kidney Diseases at Louisiana State University Health Sciences Center and published in the May issue* of The Journal of Clinical Investigation.

The scientists found that low concentrations of sodium nitrite had a strong protective effect - preventing cell death in the hearts and livers of mice undergoing experimental heart attack and liver injury.

In the heart study, nitrite reduced the size of the area of dead tissue known as an infarct by 67 percent compared to control animals given nitrate, another nitrogen compound. This potent protective effect was observed at concentrations of nitrite in blood that were only slightly higher than the physiological normal levels in blood.

The study, led by David Lefer, Ph.D., of Louisiana State University Health Sciences Center in Shreveport and Mark Gladwin, M.D., Head of the Vascular Therapeutics Section of the NHLBI's Cardiovascular Branch, follows another study conducted by the NIH research team that found that infusions of sodium nitrite into the human circulation leads to the production of nitric oxide ( NO ), a strong blood vessel dilating molecule that increases blood flow. The conversion of nitrite to NO will occur only in tissue or blood that is very low in oxygen. It was this finding that triggered the team's interest in sodium nitrite as a treatment/preventive for the tissue damage and cell death that can occur in conjunction with organ transplantation, heart attack, and treatment of a heart attack.

In both the liver and heart components of the current study, the research team compared the effects of both lower and higher concentrations of nitrite versus control treatments of saline or nitrate, a chemical compound that is related to nitrite but cannot convert to NO in the blood. Surprisingly, they found that only low concentrations of nitrite provided protection against injury.

The investigators are currently studying the mechanism for the protective effect of sodium nitrite and they believe it is related in some way to the conversion of nitrite to nitric oxide.

"The remarkable thing about nitrite is that it is only converted to nitric oxide in the organs and tissues with the lowest oxygen levels, allowing for targeted NO delivery - and thus improved blood flow -- to tissues under stress. More research is needed to look at the effectiveness of nitrite in various organs and disease states in humans," said NHLBI's Gladwin who is also an investigator in the Critical Care Medicine Department, NIH Clinical Center.

Gladwin is currently studying the use of sodium nitrite as a way to help adults with sickle cell disease. It is hoped that this treatment will reverse the effect of decreased blood flow due to the patients' "sickled" blood cells. Patients with sickle cell disease have abnormal hemoglobin molecules in their red blood cells. The molecules damage the red cells, causing them to change into a crescent or sickle shape and stick to blood vessel walls. This can lead to narrowed, or blocked, blood vessels leading to pain, damage, and anemia.

Further studies either underway or in planning translate the new findings to humans. These studies evaluate sodium nitrite's effect on heart attacks, kidney failure, solid organ transplantation, cerebral vasospasm ( a complication of a ruptured aneurysm leading to reduced blood flow and possible stroke ), and high blood pressure in the lungs in babies.



Publication: The study to be published in the May issue of The Journal of Clinical Investigation
On the web: www.nhlbi.nih.gov 

Advertise in this space for $10 per month. Contact us today.


Related Latest Research News


Subscribe to Latest Research Newsletter

Enter your email address:


 Additional information about the news article
To arrange an interview with Dr. Gladwin, contact the NHLBI Communications Office at 301-496-4236. To interview Dr. Lefer, contact the LSU Office of Information Services at 318-675-5408.

NHLBI is part of the National Institutes of Health ( NIH ), the Federal Government's primary agency for biomedical and behavioral research. NIH is a component of the U.S. Department of Health and Human Services. NHLBI press releases and fact sheets, including a fact sheet on sickle cell anemia, can be found online at http://www.nhlbi.nih.gov

*"Cytoprotective Effects of Nitrite During In Vivo Ischemia-Reperfusion of the Heart and Liver" appears online on the Journal of Clinical Investigation Web Site - in advance of the print publication of the May issue.

Contact: NHLBI Communications Office
[email protected]
301-496-4236
NIH/National Heart, Lung, and Blood Institute
http://www.nhlbi.nih.gov
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)